CUL1 promotes trophoblast cell invasion at the maternal-fetal interface

Cell Death and Disease

Volumn 4, Issue 2, 2013, Pages

  Zhang, Q ^a,b   Chen, Q ^b   Lu, X ^a,c   Zhou, Z ^a,c   Zhang, H ^d   Lin, H Y ^a   Duan, E ^a   Zhu, C ^a   Tan, Y ^b   Wang, H ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cullin1; Invasion migration; Placenta; Pre eclampsia; Syncytialization

Indexed keywords

FORSKOLIN; GELATINASE B; PROTEIN CULLIN 1; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; CHORIOCARCINOMA; CHORION VILLUS; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL; TROPHOBLAST;

CELL FUSION; CELL MOVEMENT; CELLS, CULTURED; CHORIONIC VILLI; CULLIN PROTEINS; FEMALE; FORSKOLIN; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RNA INTERFERENCE; RNA, SMALL INTERFERING; STEM CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TROPHOBLASTS;

EID: 84875969370     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.1     Document Type: Article

References (38)

1. Vicovac L, Aplin JD. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat (Basel) 1996; 156: 202-216.
2. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004; 114: 744-754.
3. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W et al. Macrophageinduced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001; 81: 1143-1152.
4. Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 54: 269-280.
5. Bischof P, Meisser A, Campana A. Paracrine and autocrine regulators of trophoblast invasion-a review. Placenta 2000; 21 (Suppl A): S55-S60.
6. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369-381.
7. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6: 9-20.
8. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416: 703-709.
9. Dealy MJ, Nguyen KV, Lo J, Gstaiger M, Krek W, Elson D et al. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet 1999; 23: 245-248.
10. Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev 1999; 13: 2375-2387.
11. Li B, Ruiz JC, Chun KT. CUL-4A is critical for early embryonic development. Mol Cell Biol 2002; 22: 4997-5005.
12. Gascoin-Lachambre G, Buffat C, Rebourcet R, Chelbi ST, Rigourd V, Mondon F et al. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta 2010; 31: 151-157.
13. Huber C, Dias-Santagata D, Glaser A, O'Sullivan J, Brauner R, Wu K et al. Identification of mutations in CUL7 in 3-M syndrome. Nat Genet 2005; 37: 1119-1124.
14. Maksimova N, Hara K, Miyashia A, Nikolaeva I, Shiga A, Nogovicina A et al. Clinical, molecular and histopathological features of short stature syndrome with novel CUL7 mutation in Yakuts: new population isolate in Asia. J Med Genet 2007; 44: 772-778.
15. Fu J, Lv X, Lin H, Wu L, Wang R, Zhou Z et al. Ubiquitin ligase cullin 7 induces epithelial-mesenchymal transition in human choriocarcinoma cells. J Biol Chem 2010; 285: 10870-10879.
16. Wang HX, Wang HM, Lin HY, Yang Q, Zhang H, Tsang BK et al. Proteasome subunit LMP2 is required for matrix metalloproteinase-2 and -9 expression and activities in human invasive extravillous trophoblast cell line. J Cell Physiol 2006; 206: 616-623.
17. Gauster M, Moser G, Orendi K, Huppertz B. Factors involved in regulating trophoblast fusion: potential role in the development of preeclampsia. Placenta 2009; 30 (Suppl A): S49-S54.
18. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 1996; 85: 829-839.
19. Michel JJ, Xiong Y. Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ 1998; 9: 435-449.
20. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 2003; 37: 735-749.
21. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol May 12: 457-467.
22. Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 2003; 24: 575-587.
23. Varanou A, Withington SL, Lakasing L, Williamson C, Burton GJ, Hemberger M. The importance of cysteine cathepsin proteases for placental development. J Mol Med (Berl) 2006; 84: 305-317.
24. Lala PK, Graham CH. Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev 1990; 9: 369-379.
25. Schatz F, Lockwood CJ. Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab 1993; 77: 621-625.
26. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113: 437-449.
27. Yu C, Shen K, Lin M, Chen P, Lin C, Chang GD et al. GCMa regulates the syncytinmediated trophoblastic fusion. J Biol Chem 2002; 277: 50062-50068.
28. Baczyk D, Drewlo S, Proctor L, Dunk C, Lye S, Kingdom J. Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 2009; 16: 719-727.
29. Chiang MH, Chen LF, Chen H. Ubiquitin-conjugating enzyme UBE2D2 is responsible for FBXW2 (F-box and WD repeat domain containing 2)-mediated human GCM1 (glial cell missing homolog 1) ubiquitination and degradation. Biol Reprod 2008; 79: 914-920.
30. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56.
31. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002; 287: 3183-3186.
32. George EM, Granger JP. Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol 2010; 5: 557-566.
33. Zhou Z, Shen T, Zhang BH, Lv XY, Lin HY, Zhu C et al. The proprotein convertase furin in human trophoblast: possible role in promoting trophoblast cell migration and invasion. Placenta 2009; 30: 929-938.
34. Matsuura K, Jigami T, Taniue K, Morishita Y, Adachi S, Senda T et al. Identification of a link between Wnt/beta-catenin signalling and the cell fusion pathway. Nat Commun 2011; 2: 548.
35. Genbacev O, Jensen KD, Powlin SS, Miller RK. In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. Placenta 1993; 14: 463-475.
36. Soares MJ, Hunt JS. Placenta and trophoblast: methods and protocols: overview II. Methods Mol Med 2006; 122: 3-7.
37. Fu JJ, Lin P, Lv XY, Yan XJ, Wang HX, Zhu C et al. Low molecular mass polypeptide-2 in human trophoblast: over-expression in hydatidiform moles and possible role in trophoblast cell invasion. Placenta 2009; 30: 305-312.
38. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 2000; 60: 5659-5666.